Intermediate filament proteins and their associated diseases

New England Journal of Medicine

Volumn 351, Issue 20, 2004, Pages 2087-2100

  Omary, M Bishr ^a,d   Coulombe, Pierre A ^b   McLean, W H Irwin ^c  

^a STANFORD UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERMEDIATE FILAMENT PROTEIN;

CYTOSKELETON; DEGENERATIVE DISEASE; HAIR DISEASE; INTERMEDIATE FILAMENT; LENS DISEASE; MYOPATHY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SKIN DISEASE;

CYTOPLASM; GENE EXPRESSION REGULATION; HAIR DISEASES; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MUTATION; NEURODEGENERATIVE DISEASES; SKIN DISEASES;

EID: 6344273968     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra040319     Document Type: Review

References (108)

1. Ku N-O, Zhou X, Toivola DM, Omary MB. The cytoskeleton of digestive epithelia in health and disease. Am J Physiol 1999;277:G1108-G1137.
2. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science 1998;279:514-9.
3. Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TM. Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int Rev Cytol 2003;223:83-175.
4. Hesse M, Magin TM, Weber K. Genes for intermediate filament proteins and the draft sequence of the human genome: novel keratin genes and a surprisingly high number of pseudogenes related to keratin genes 8 and 18. J Cell Sci 2001;114:2569-75.
5. Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet 2004;41:304-8.
6. Hoffmann K, Dreger CK, Olins AL, et al. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly). Nat Genet 2002;31:410-4.
7. National Institutes of Health Office of Rare Diseases. (Accessed October 18, 2004, at http://rarediseases.info.nih.gov.)
8. Erber A, Riemer D, Bovenschulte M, Weber K. Molecular phytogeny of metazoan intermediate filament proteins. J Mol Evol 1998;47:751-62.
9. Ausmees N, Kuhn JR, Jacobs-Wagner C. The bacterial cytoskeleton: an intermediate filament-like function in cell shape. Cell 2003;115:705-13.
10. Coulombe PA, Omary MB. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 2002;14:110-22.
11. Irvine AD, McLean WH. Human keratin diseases: the in creasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999;140:815-28.
12. Porter RM, Lane EB. Phenotypes, genotypes and their contribution to understandingkeratin function. Trends Genet 2003;19:278-85.
13. Li R, Messing A, Goldman JE, Brenner M. GFAP mutations in Alexander disease. Int J Dev Neurosci 2002;20:259-68.
14. Lariviere RC, Julien JP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol 2004;58:131-48.
15. Worman HJ, Courvalin JC. How do mutations in lamins A and C cause disease? J Clin Invest 2004;113:349-51.
16. Al-Chalabi A, Miller CCJ. Neurofilaments and neurological disease. Bioessays 2003;25:346-55.
17. Novelli G, D'Apice MR, The strange case of the "lumper" lamin A/C gene and human premature aging. Trends Mol Med 2003;9:370-5.
18. Holtz D, Tanaka RA, Hartwig J, McKeon F. The CaaX motif of lamin A functions in conjunction with the nuclear localization signal to target assembly to the nuclear envelope. Cell 1989;59:969-77.
19. Inagaki M, Matsuoka Y, Tsujimura K, et al. Dynamic property of intermediate filaments: regulation by phosphorylation. Bioessays 1996;18:481-7.
20. Grant P, Pant HC. Neurofilament protein synthesis and phosphorylation. J Neurocytol 2000;29:843-72.
21. Candi E, Tarcsa E, Digiovanna JJ, et al. A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminases. Proc Natl Acad Sci U S A 1998;95:2067-72.
22. Dong DL, Xu ZS, Hart GW, Cleveland DW. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J Biol Chem 1996;271:20845-52.
23. Helfend BT, Chang L, Goldman RD. The dynamic and motile properties of intermediate filaments. Annu Rev Cell Dev Biol 2003;19:445-67.
24. Oshima RG. Apoptosis and keratin intermediate filaments. Cell Death Differ 2002;9:486-92.
25. Chen F, Chang R, Trivedi M, Capetanaki Y, Cryns VL. Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis. J Biol Chem 2003;278:6848-53.
26. Green KJ, Gaudry CA. Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol 2000;1:208-16.
27. Jefferson JJ, Leung CL, Liem RK. Plakins: goliaths that link cell junctions and the cytoskeleton. Nat Rev Mol Cell Biol 2004;5:542-53.
28. Zasttow MS, Vlcek S, Wilson KL. Proteins that bind A-type lamins: integrating isolated clues. J Cell Sci 2004;117:979-87.
29. Coulombe PA, Wong P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat Cell Biol 2004;6:699-706.
30. Fickert P, Trauner M, Fuchsbichler A, Stumptner C, Zatloukal K, Denk H. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. J Hepatol 2003;38:387-94.
31. Toivola DM, Ku N-O, Resurreccion EZ, Nelson DR, Wright TL, Omary MB. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 2004;40:459-66.
32. Wong P, Coulombe PA. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J Cell Biol 2003;163:327-37.
33. Zhong B, Zhou Q, Toivola DM, Tao G-Z, Resurreccion EZ, Omary MB. Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kB activation. J Cell Sci 2004;117:1709-19.
34. Denk H, Stumptner C, Zatloukal K. Mallory bodies revisited. J Hepatol 2000;32:689-702.
35. Goebel HH. Congenital myopathies at their molecular dawning. Muscle Nerve 2003;27:527-48.
36. Ku N-O, Darling JM, Krams SM, et al. Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc Natl Acad Sci U S A 2003;100:6063-8.
37. Ku N-O, Soetikno RM, Omary MB. Keratin mutation in transgenic mice predisposes to FAS but not TNF-induced apoptosis and massive liver injury. Hepatology 2003;37:1006-14.
38. Coulombe PA, Hutton ME, Letai A, Hebert A, Palier AS, Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 1991;66:1301-11.
39. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/exttacellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol 2004;24:7072-81.
40. Bruijn LI, Miller TM, Cleveland DW. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004;27:723-49.
41. Bonifas JM, Rothman AL, Epstein EH Jr. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 1991;254:1202-5.
42. Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem 1998;31:205-62.
43. Kramer G, Erdal H, Mertens HJ, et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 2004;64:1751-6.
44. Leers MP, Schoffelen RH, Hoop JG, et al. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer. J Clin Pathol 2002;55:359-66.
45. Anton-Lamprecht I, Schnyder UW. Epidermolysis bullosa herpetiformis Dowling-Meara: report of a case and pathomorphogenesis. Dermatologica 1982;164:221-35.
46. Albers K, Fuchs E. The expression of mutant epidermal keratin cDNAs transfected in simple epithelial and squamous cell carcinoma lines. J Cell Biol 1987;105:791-806.
47. Vassar R, Coulombe PA, Degenstein L, Albers K, Fuchs E. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 1991;64:365-80.
48. Lane EB, Rugg EL, Navsaria H, et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992;356:244-6.
49. Cheng J, Syder AJ, Yu Q-C, Letai A, Paller AS, Fuchs E. The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell 1992;70:811-9.
50. Chipev CC, Korge BP, Markova N, et al. A leucine-proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992;70:821-8.
51. Human Intermediate Filament Mutation Database. (Accessed October 18, 2004, at http://www.interfil.org.)
52. Terron-Kwiatkowski A, Paller AS, Compton J, Atherton DJ, McLean WH, Irvine AD. Two cases of primarily palmoplantar keratoderma associated with novel mutations in keratin 1. J Invest Dermatol 2002;119:966-71.
53. Owens DW, Wilson NJ, Hill AJM, et al. Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J Cell Sci 2004;117:1989-99.
54. Cavestro GM, Frulloni L, Nouvenne A, et al. Association of keratin 8 gene mutation with chronic pancreatitis. Dig Liver Dis 2003;35:416-20.
55. Langbein L, Rogers MA, Winter H, Praetzel S, Schweizer J. The catalog of human hair keratins. II. Expression of the six type II members in the hair follicle and the combined catalog of human type I and II keratins. J Biol Chem 2001;276:35123-32.
56. Winter H, Rogers MA, Langbein L, et al. Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet 1997;16:372-4.
57. Chapalain V, Winter H, Langbein L, et al. Is the loose anagen hair syndrome a keratin disorder? A clinical and molecular study. Arch Dermatol 2002;138:501-6.
58. Winter H, Schissel D, Parry DA, et al. An unusual Alal2Thr polymorphism in the 1Aα-helical segment of the companion layer-specific keratin K6hf: evidence for a risk factor in the etiology of the common hair disorder pseudofolliculitis barbae. J Invest Dermatol 2004;122:652-7.
59. Munoz-Marmol AM, Strasser G, Isamat M, et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci U S A 1998;95:11312-7.
60. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldrarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000;342:770-80.
61. Berry V, Francis P, Reddy MA, et al. Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet 2001;69:1141-5.
62. Jakobs PM, Hess JF, FitzGerald PG, Kramer P, Weleber RG, Litt M. Autosomal-dominant congenital cataract associated with a deletion mutation in the human beaded filament protein gene BFSP2. Am J Hum Genet 2000;66:1432-6.
63. Conley YP, Erturk D, Keverline A, et al. A juvenile-onset, progressive cataract locus on chromosome 3q21-q22 is associated with a missense mutation in the beaded filament structural protein-2. Am J Hum Genet 2000;66:1426-31.
64. Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001;27:117-20.
65. Mersiyanova IV, Perepelov AV, Polyakov AV, et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 2000;67:37-46.
66. Gros-Louis F, Lariviere R, Gowing G, et al. A frameshift deletion in peripherin gene associated with amyotrophic lateral sclerosis. J Biol Chem (in press).
67. Jonkman MF. Hereditary skin diseases of hemidesmosomes. J Dermatol Sci 1999;20:103-21.
68. Wiche G. Role of plectin in cytoskeleton organization and dynamics. J Cell Sci 1998;111:2477-86.
69. Perez-Olle R, Jones ST, Liem RK. Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models. Hum Mol Genet 2004;13:2207-20.
70. McGowan KM, Tong X, Colucci-Guyon E, Langa F, Babinet C, Coulombe PA. Keratin 17 null mice exhibit age- and strain-dependent alopecia. Genes Dev 2002;16:1412-22.
71. Jonkman MF, Heeres K, Pas HH, et al. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J Invest Dermatol 1996;107:764-9.
72. Zhou Q, Toivola DM, Feng N, Greenberg HB, Franke WW, Omary MB. Keratin 20 helps maintain intermediate filament organization in intestinal epithelia. Mol Biol Cell 2003;14:2959-71.
73. Beil M, Micoulet A, von Wiehert G, et al. Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells. Nat Cell Biol 2003;5:803-11.
74. Ma L, Yamada S, Wirtz D, Coulombe PA. A 'hot-spot' mutation alters the mechanical properties of keratin filament networks. Nat Cell Biol 2001;3:503-6.
75. Werner NS, Windoffer R, Strnad P, Grund C, Leube RE, Magin TM. Epidermolysis bullosa simplex-type mutations alter the dynamics of the keratin cytoskeleton and reveal a contribution of actin to the transport of keratin subunits. Mol Biol Cell 2004;15:990-1002.
76. Uttam J, Hutton E, Coulombe PA, et al. The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci U S A 1996;93:9079-84.
77. Ameen NA, Figueroa Y, Salas PJ. Anomalous apical plasma membrane phenotype in CK8-deficient mice indicates a novel role for intermediate filaments in the polarization of simple epithelia. J Cell Sci 2001;114:563-75.
78. Toivola DM, Krishnan S, Binder HJ, Singh SK, Omary MB. Keratins modulate colonocyte electrolyte transport via protein mistargeting. J Cell Biol 2004;164:911-21.
79. Milner DJ, Mavroidis M, Weisleder N, Capetanald Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000;150:1283-98.
80. D'Alessandro M, Russell D, Morley SM, Davies AM, Lane EB. Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock. J Cell Sci 2002;115:4341-51.
81. Baribault H, Penner J, Iozzo RV, Wilson-Heiner M. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev 1994;8:2964-73.
82. van der Kooi AJ, Bonne G, Eymard B, et al. Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 2002;59:620-3.
83. Bonne G, Di Barletta MR, Varnous S, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999;21:285-8.
84. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999;341:1715-24.
85. Hegele RA. Lamin mutations come of age. Nat Med 2003;9:644-5.
86. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003;423:293-8.
87. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin A truncation in Hutchinson-Gilford progeria. Science 2003;300:2055.
88. Leiden Muscular Dystrophy pages: lamin A/C (LMNA). (Accessed October 18, 2004, at http://www.dmd.nl/lmna_home.html#disease.)
89. Novelli G, Muchir A, Sangiuolo F, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 2002;71:426-31.
90. Sullivan T, Escalante-Akalde D, Bhatt H, et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999;147:913-20.
91. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002;70:726-36. [Erratum, Am J Hum Genet 2002;70:1075.]
92. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 2002;70:726-36. [Erratum, Am J Hum Genet 2002;70:1075.]
93. Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL. A progeroid syndrome in mice is caused by defects in A-type lamins. Nature 2003;423:298-301.
94. Garg A. Acquired and inherited lipodystrophies. N Engl J Med 2004;350:1220-34.
95. Hutchison CJ. Lamins: building blocks or regulators of gene expression? Nat Rev Mol Cell Biol 2002;3:848-58.
96. Taniura H, Glass C, Gerace L. A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones. J Cell Biol 1995;131:33-44.
97. Lloyd DJ, Trembath RC, Shackleton S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002;11:769-77.
98. Muchk A, van Engelen BG, Lammens M, et al. Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp Cell Res 2003;291:352-62.
99. Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest 2002;110:1383-8.
100. Krimm I, Ostlund C, Gilquin B, et al. The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure (Camb) 2002;10:811-23.
101. Dhe-Paganon S, Werner ED, Chi YI, Shoelson SE. Structure of the globular tail of nuclear lamin. J Biol Chem 2002;277:17381-4.
102. Uitto J, Pfendner E, Jackson LG. Probing the fetal genome: progress in non-invasive prenatal diagnosis. Trends Mol Med 2003;9:339-43.
103. Cao T, Longley MA, Wang XI, Roop DR. An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy. J Cell Biol 2001;152:651-6.
104. Kinouchi R, Takeda M, Yang L, et al. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin. Nat Neurosci 2003;6:863-8.
105. D'Alessandro M, Morley SM, Ogden PH, Liovic M, Porter RM, Lane EB. Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseases. Gene Ther 2004;11:1290-5.
106. Kirfel J, Peters B, Grund C, Reifenberg K, Magin TM. Ectopic expression of desmin in the epidermis of transgenic mice permits development of a normal epidermis. Differentiation 2002;70:56-68.
107. Chavez Zobel AT, Loranger A, Marceau N, Theriault JR, Lambert H, Landry J. Distinct chaperone mechanisms can delay the formation of aggresomes by the myopathycausing R120G alphaB-crystallin mutant. Hum Mol Genet 2003;12:1609-20.
108. Weisleder N, Taffet GE, Capetanaki Y. Bcl-2 overexpression corrects mitochondrial detects and ameliorates inherited desmin null cardiomyopathy. Proc Natl Acad Sci U S A 2004;101:769-74.